Sunil Agarwal is Director of ARVINAS, INC.. Currently has a direct ownership of 14,141 shares of ARVN, which is worth approximately $354,514. The most recent transaction as insider was on May 29, 2024, when has been sold 5,899 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.1K
0% 3M change
71.57% 12M change
Total Value Held $354,514

SUNIL AGARWAL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
BUY
Grant, award, or other acquisition
-
5,899 Added 29.44%
14,141 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
8,242 Added 50.0%
8,242 Common Stock

Also insider at

MYOK
MyoKardia Inc
SANA
Sana Biotechnology, Inc. Healthcare
CALA
Calithera Biosciences, Inc. Healthcare
ATXS
Astria Therapeutics, Inc. Healthcare
SA

Sunil Agarwal

Director
Seattle, WA

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Track Activities on ARVN